2. Other chronic diseases Neurodegenerative diseases
ABOUT US
University of Oviedo
Business Angels:
Celiac disease
Prostate Cancer
Alzheimer’s disease
Other chronic diseases
Develop, manufacture and marketing high-sensitivity and reliable electrochemical biosensors to be used in diagnosis of diseases with a high prevalence in the population.
ACTIVITY
BIOMARKERS
DIAGNOSIS
PROGNOSIS
Autoimmune diseases
Tumoral markers
Neurodegenerative diseases

3. WHAT HAVE WE DONE AWARDS
Genoma Spain
ACTIVITY BEGINING
CONSTITUTION
MARKET
Product development
Celiac disease
PSA
Creatinine
IV Award to the best innovative technology-based business project (2009)
AWARDS
XVI SODECO Award to business project (2009)

4. Biomodified electrodic surface Portable detection system
OUR TECHNOLOGY
Telemedicine
Interpretation
Blood
Saliva
Urine
Detection Reactive
Biomodified electrodic surface
Biomarkers
Portable detection system

5. SIMULTANEOUS ANALYSIS NON-INVASIVE EXTRACTION
INNOVATIVE ASPECTS
MINIATURIZATION
INNOVATION
DECENTRALIZATION
UNSKILLED PERSONAL
SIMULTANEOUS ANALYSIS
NON-INVASIVE EXTRACTION

6. Spanish population pyramid for 2030
BIOMARKERS AND PREVENTION
Spanish population pyramid for 2030
Men
Women
When prevention fails
The cost of illness in United Kingdom in 2002 (in millions of pounds)
HEALTH EXPEDITURE DUE TO OBESITY (in % of total health expediture)
2’5 %
2 %
2’4 %
3’5 %
6 %

7. POTENTIAL CUSTOMERS Ambulances and Emergency Units Drugstores
Telemedicine
Health Center

8. Damaged villi of small intestine
CELIAC DISEASE
Damaged villi of small intestine
Healthy normal villi
The usual prevalence of celiac disease is approximately 1% of the population in developed countries, although actual prevalence is of 3-5% of the population in developed countries.

9. PROSTATE CANCER INCIDENCE (nº/100.000 people)
< 7.5
< 14
< 25
< 41
< 125
PROSTATE CANCER INCIDENCE (nº/ people)
Normal prostate
Prostate Cancer
new cases every year in Spain
After a prostatectomy it is necessary to have a more accurate control of PSA levels
PSA levels can distinguish between cancer and BPH

10. Early detection (biomarkers) Diagnosis (classical methods)
ALZHEIMER’s DISEASE
affected in Spain ( new patients every year)
2 million people indirectly affected
8 million affected in Europe
Aging of the population; prevalence will triplicate in 2050
In USA, direct and indirect annual costs of caring for individuals with Alzheimer's disease are at least $100 billion
Early detection can delay the onset of symptoms
Years
Progressive
functional loss
Early detection (biomarkers)
Diagnosis (classical methods)
Preclinical phase
Clinical phase

11. Renal function indicator POC creatinine monitoring system
RENAL FAILURE
Creatinine in blood
Renal function indicator
POC creatinine monitoring system
test per year at HUCA
With a POC for creatinine a better control can be achieved

12. WHERE WE ARE HEALTHSENS SL Hospital Universitario Central de Asturias
Julian Claveria Street, Polyvalent Block A, 4th
33006, Oviedo (Asturias), Spain
Phone: (+34)

13. Thanks for you attention !
ACKNOWLEDGMENTS
Thanks for you attention !